Aptar CSP Technologies is the premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process, and provides complete solutions that improve consumers' and patients' lives.
Based on breakthrough science, Aptar CSP Technologies' proprietary 3-Phase Activ-Polymer technology enables the development of innovative, highly engineered material science based solutions to meet a broad range of product stability needs across six key therapeutic areas.We offer a complete spectrum of capabilities to support our customers and expedite speed-to-market.
Based on breakthrough science, Aptar CSP Technologies' proprietary 3-Phase Activ-Polymer technology enables the development of innovative, highly engineered material science based solutions to meet a broad range of product stability needs across six key therapeutic areas.We offer a complete spectrum of capabilities to support our customers and expedite speed-to-market.
Services
Aptar CSP Technologies is a true innovation partner, offering a complete suite of services to assist our customers from concept ideation through commercialization. Our experienced teams can support you throughout any stage of the development process and apply their depth of expertise to assure your projects have the best possible outcomes.
Many drugs can be administered in oral solid dose form as capsules, tablets, or chewable tablets. Activ-Blister Solutions provides drug product specific protection to address growing stability limitations in a blister packaging format.
This innovative technology integrates Aptar's proprietary 3-Phase Activ-Polymer film into each individual blister cavity to provide the ideal microclimate to protect tablets or capsules inside a thermoformed blister package.Using highly-engineered 3-Phase Activ-Polymer technology, Activ-Blister can adsorb tailored amounts of water vapor, scavenge oxygen or VOCs, or provide a combination of active protection.
This innovative technology integrates Aptar's proprietary 3-Phase Activ-Polymer film into each individual blister cavity to provide the ideal microclimate to protect tablets or capsules inside a thermoformed blister package.Using highly-engineered 3-Phase Activ-Polymer technology, Activ-Blister can adsorb tailored amounts of water vapor, scavenge oxygen or VOCs, or provide a combination of active protection.
Dermal and transdermal drug delivery systems are a growing drug administration route, offering an easy-to-use, patient-friendly, and highly reliable solution that enables higher bioavailability for small molecules and biologics. Providing convenient and pain-free self-administration for patients, this drug delivery method can eliminate the need for frequent dosing and provide a consistent amount of API to the patient for long-term treatment.
Medical devices and implants face a unique set of challenges inherent to these types of delivery systems that must be addressed to ensure optimal performance. The complete system is affected by environmental conditions (moisture, temperature changes, VOCs, etc.) that can result in degradation of the drug substance, reduced potency, and ultimately deliver sub-therapeutic levels to patients.
Inhaled drug delivery systems face unique stability challenges that need to be managed in order to meet label claim dosages and improve patient compliance.
From keeping powder formulations dry within a delivery system, to controlling the build-up of powder in the delivery channel, to maintaining the integrity of APIs within capsule- and reservoir-based DPIs (dry powder inhalers) and pMDIs (pressurized metered-dose inhalers), Aptar CSP Technologies can custom-design a solution to meet your drug product's needs so you can deliver an optimal patient and consumer experience.
From keeping powder formulations dry within a delivery system, to controlling the build-up of powder in the delivery channel, to maintaining the integrity of APIs within capsule- and reservoir-based DPIs (dry powder inhalers) and pMDIs (pressurized metered-dose inhalers), Aptar CSP Technologies can custom-design a solution to meet your drug product's needs so you can deliver an optimal patient and consumer experience.
Reviews
Be the first to review CS&P Technologies Canada.
Write a Review